title: Osteosarcoma: A Meta-Analysis and Review of the Literature.
abstract: Over the past 30 years, treatment advances and the addition of neoadjuvant chemotherapy have led to improved 5-year survival in patients with osteosarcoma. More recent literature suggests the overall prognosis remains highly variable, with little improvement since the introduction of neoadjuvant chemotherapy. Tumor necrosis is an important predictor of patient prognosis. Necrosis of more than 90% correlates with overall survival (OS) approaching 75%. We reviewed the history of osteosarcoma treatment and survival and performed a meta-analysis of the 2000-2011 literature. Forty articles were included in the study. Five-year OS was 63% (95% confidence interval, 60%-66%) in studies that included patients with metastatic and nonmetastatic disease and 71% (95% confidence interval, 67%-76%) in studies that included only patients with nonmetastatic disease. Fifty percent of the patients in the studies of those with nonmetastatic osteosarcoma achieved 90% necrosis on histology. Five-year OS and number of patients achieving 90% necrosis are consistent with previous reports. Research is needed to improve treatment regimens and patient outcomes.
authors.forename: Jill C
authors.initials: JC
authors.lastname: Friebele
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Peck
authors.forename: Xueliang
authors.initials: X
authors.lastname: Pan
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Abdel-Rasoul
authors.affiliation: Arthur James Cancer Hospital, Ohio State University, Columbus, OH. joel.mayerson@osumc.edu.
authors.forename: Joel L
authors.initials: JL
authors.lastname: Mayerson
mesh_terms: D001859:Bone Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D003131:Combined Modality Therapy; D019468:Disease Management; D014943:Global Health; D006801:Humans; D009017:Morbidity / Q000639:trends; D009367:Neoplasm Staging; D012516:Osteosarcoma / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D015996:Survival Rate / Q000639:trends